The present study was undertaken to evaluate the efficacy of freeze dried extract of Sida rhomboidea.roxb leaves (FESR) on alteration in lipid and cholesterol metabolism in high fat diet induced hyperlipidemia in experimental rats. Plasma and hepatic lipid profiles, lipid and cholesterol metabolizing enzymes in target tissues and fecal total lipids and bile acid contents were evaluated in FESR treated normolipidemic and hyperlipidemic rats. These results were compared with synthetic hypolipidemic drug lovastatin (LVS). Results indicate that FESR was able to positively regulate induced experimental hyperlipidemia by significant alteration in plasma and tissue lipid profiles. These results can be attributed to reduced absorption, effective elimination and augmented catabolism of lipids and cholesterol possibly due to high content of saponin and phytosterols in S. Rhomboidea. roxb (SR). Use of SR extract as a potential therapeutic agent against hyperlipidemia is indicated.
INTRODUCTION
Excessive dietary lipids and cholesterol are the major factors of relevance for the development of hypertriglyceridemia and hypercholesterolemia, two important cardiovascular risk factors. 1, 2) Hyperlipidemia, hypercholesterolemia, obesity, sedentary lifestyle etc are the key risk factors leading to cardiovascular disorders (CVD) 3) and, also the most common causes of death in developed as well as developing countries. 4) Some of the major limitations in the effective pharmacological treatment of hyperlipidemia are the constraints imposed on healthcare resources, particularly in the low-and middleincome countries. 5) There is a need to tackle this physiological problem as it is attaining grave proportions globally. In this scenario, the problem may be tackled by the use of natural agents due to their cost effectiveness and minimal side-effects. 6) In recent times, much research interest has been focused * To whom correspondence should be addressed: Division of Phytotherapeutics and Metabolic Endocrinology, Department of Zoology, Faculty of Science, The Maharaja SayajiRao University of Baroda, Vadodara-390002, Gujarat, India. Tel.: +91-9825935445; Fax: +91-02652226425; E-mail: phyto met@yahoo.com on various herbs that possess hypolipidemic properties that may be useful in reducing the risk of cardiovascular diseases. 7) Sida rhomboidea. roxb (SR, Syn. S. rhombifolia linn, fam. Malvaceae) is a shrubby weed found growing throughout India. In ayurveda, it is known as "Mahabala." 8) Phytochemical analysis of the aerial parts has shown presence of n-alkanes, long chain alcohols, sterol, ephedrine, sterculic acid, linoleic acid, phenyl ethylamines, cellulose and lignin. 9, 10) It has been shown to have significant anti-inflammatory cum antipyretic 11) and antibacterial 12) effects along with antinociceptive 13) and hepatoprotective abilities. 14) It is also considered beneficial in controlling fever, cardiovascular diseases and urinary disorders. 15) It is used in many parts of North Eastern India as a home remedy against obesity and diabetes. The present inventory is in this behest an attempt to evaluate the efficacy of SR extract on the induced alterations in lipid and cholesterol metabolisms in high fat diet fed hyperlipidemic rats.
MATERIALS AND METHODS
Plant Material --SR leaves were collected from imphal district India in the month of June and shade dried. The plant was identified at the Department of Botany, Dhana Manjuri College of Science Manipur, Imphal and a sample (voucher specimen No.216) was deposited at the herbarium of the Department of Botany. Preparation of Freeze Dried Extract --Leaves of SR were shade dried and fine powdered. Hundred grams of powdered leaves was boiled in distilled water at 100 • C for 3 hr. Resulting filtrate was concentrated by heating to obtain a semisolid paste that was later freeze dried resulting in a total yield of 24% w/w. Different doses of freeze dried extract SR leaves (FESR) were prepared by dissolving a known weight of dried paste in 0.5% carboxy methylcellulose (CMC). Phytochemical Analysis --The quantitative phytochemical analysis of SR leaves for saponins, 16) phytosterols, 17) ascorbic acid, 18) polyphenols, 19) and flavanoids 20) was carried out. Experimental Animals --Female Charles foster albino rats (180-220 g) were housed and maintained in clean polypropylene cages under controlled room temperature (16 ± 2 • C) and were fed with commercially available rat chow (Standard Laboratory Diet (SLD); M/s Pranav Agro Ltd., Baroda, India) or hyperlipidemic diet (HFD) 21) and provided with water ad libitum. Experiments on animals were performed in accordance with guidelines of the Institutional animal ethical committee (Approval No.827/ac/04/Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA)). Experimental Design --Fifty four animals were divided into 9 groups (n = 6 per group). Groups I and V were fed with SLD and HFD respectively. Groups II, III, and IV were maintained on SLD and orally administered with 200, 400 or 800 mg/kg FESR extract daily. Groups VI, VII and VIII were maintained on HFD and administered with FESR extract as mentioned above. Group IX was fed with HFD and synthetic hypolipidemic agent, lovastatin (LVS; 5 mg/kg BW). Animals were maintained for a total of 42 days during which they were orally administered with vehicle, extract or LVS by gastric intubation. Lipid Profile --Plasma total lipids were assayed by the method of Frings et al. 22) Plasma total cholesterol (TC), triglycerides (TG) and high density lipoprotein (HDL) were analyzed using commercially available kits (Merck diagnostics, Mumbai, India). Very low density lipoproteins (VLDL) and low density lipoprotein (LDL) were calculated by Friedwald's formula. 23) Hepatic and fecal lipids were extracted in chloroform: methanol (2 : 1) mixture and dried. Total lipids (TL) were estimated by gravimetric analysis. 24) Dried lipid extract was dissolved in 1% triton X 100 25) and TC and TG were analyzed using above mentioned kits. Fecal Cholic Acid (CA) and Deoxycholic Acid (DCA) --Fecal samples from each experiment group were collected on every 3rd day between days 31 and 42 of study. Fecal samples were dried, eluted with absolute alcohol, filtered and processed for estimation of CA and DCA. 26) Estimation of Lipid Metabolizing Enzymes --Freshly excised tissues (liver and adipose tissues) were rinsed with 0.5 M KCl and kept in −80 • C for further use. Activity levels of lipoprotein lipase (LPL; EC 3.1.1.34) were estimated in fresh tissue homogenates. 27, 28) Heparin (50 units/rats) was injected intravenously to facilitate release of endothelium bound LPL, two mins before blood collection. Plasma was separated and post-heparin lypolytic activity (PHLA) was assayed. 29) Estimation of Cholesterol Metabolizing Enzymes --Activity levels of lecithin-cholesterol acyltransferase (LCAT, EC 2.3.1.43) was assayed in plasma by the method of Legraud et al., 30) with modifications by Hitz et al. 31) 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG CoA) reductase (HMG CoA reductase, EC 1.1.1.34) activity was assayed as per the method of Rao and Ramakrishnan 32) and expressed as inversely proportional to the mevalonate content. Cholesterol ester synthase (CES, EC 2.3.1.26) was assayed by the method of Kothari et al., 33) in liver and intestine.
Protein content in liver, adipose and intestine were analyzed by the method of Lowry et al. 34) Statistical Analysis --Statistical evaluation of the data was done by one way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test .The results are expressed as mean ± SEM using Graph Pad Prism version 3.0 for Windows, Graph Pad Software, San Diego, CA, U.S.A. 
RESULTS

Phytoconstituents of SR
The quantitative phytochemical analysis of FESR showed 4.5 mg/100 mg saponins, 3.0 mg/ 100 mg phytosterols, 1.9 mg/100 mg ascorbic acid, 2.0 mg/100 mg polyphenols, and 2.3 mg/100 mg flavanoids.
Body Weight and Food Intake
HFD fed rats recorded 16.56% increase in body weight whereas the weight gain in HFD+FESR fed rats showed dose dependent changes in body weight with HFD+FESR 800 mg/kg recording least increase of 8.35%. There was however no change in body weight in SLD+FESR groups as the increase was within the range of 4-6%. There was no significant change in food intake of SLD+FESR fed rats but there was a significant reduction in food intake of HFD+FESR 400 mg/kg (p < 0.01) and HFD+FESR 800 mg/kg (p < 0.001) groups (Table 1) .
Plasma and Hepatic Lipid Profiles
Though FESR per se did not have a significant effect in SLD fed rats, the extract had significant effect in reversing the altered serum and tissue lipid profiles induced by HFD, with the higher dose of 800 mg/kg being the most effective in normalizing the alterations. HFD+LVS group was also found to exert favorable effect, but was not as effective as 800 mg dose of FESR (Tables 2, 3 ).
Lipid Metabolizing Enzymes
HFD rats recorded significant decrement in activity levels of PHLA, and LPL in adipose tissue and liver (p < 0.001). HFD+FESR 200 mg/kg did not record significant increment in PHLA and LPL activities. HFD+FESR (400 and 800 mg/kg) recorded significant increments in PHLA and LPL activities compared to HFD rats (p < 0.001). HFD+LVS rats registered non significant increment in PHLA and LPL activities compared to HFD group (Table 4) . The extract had no significant effect in control rats fed with SLD (Table 4) . 
Cholesterol Metabolizing Enzymes
HFD rats recorded a significant decrement in plasma LCAT activity (p < 0.001) and increment in hepatic and intestinal CES (Table 5) . Hepatic HMG CoA reductase activity registered a non significant alteration in HFD rats compared to SLD rats. Higher doses of FESR (400 and 800 mg/kg) depicted dose dependent decrement in activity levels of HMG CoA reductase activity and increment in plasma LCAT activity (p < 0.001). Hepatic and intestinal CES activity recorded a significant decrement in HFD+FESR rats with all three doses compared to HFD rats (Table 5) . HFD+LVS rats recorded highly significant decrease in HMG CoA reductase activity (p < 0.001), a moderate decrement in Intestinal and hepatic CES activities (p < 0.01) and a non significant increment in plasma LCAT activity. The extract had no significant effect in hepatic HMG CoA reductase, plasma LCAT and CES activities in liver and Intestine when compared to SLD groups (Table 5) .
Fecal Lipid Profile and Bile Acid Content
HFD rats did not show any significant changes in fecal TL, TC, TG, cholic acid and deoxycholic acid contents (Table 6 ). The extract fed rats recorded dose dependent increment in fecal TL, TC and TG contents compared to HFD rats (Table 6) . 200 mg/kg of FESR was without any significant increment in fecal CA and DCA, while higher doses of FESR (400 and 800 mg/kg) recorded a dose dependent increment in fecal CA and DCA compared to HFD groups (p < 0.001). HFD+LVS rats recorded highly significant increment in fecal TL and TC (p < 0.001) and a non significant increment in fecal TG, CA and DCA, but definitely not as effective as 800 mg of plant extract.
DISCUSSION
Obesity and related disorders of lipid metabolism are a matter of growing concern among scientists and clinicians world over due to their implication on Non Insulin Dependent Diabetes Mellitus (NIDDM), hypertension, Coronary artery disease etc. 35) The present investigation using HFD rats shows that FESR extract (400 and 800 mg/kg) can significantly elevate plasma HDL level and reduce LDL, TC, TG and TL levels without significantly influencing the lipid profile of normolipidemic rats. Observations of changes in body weight and daily food intake suggest that HFD+FESR treatment induced no significant changes in body weight throughout the period of study but significantly decrease the daily food intake.
Phytosterols possesses greater affinity for micelles than cholesterol and reduces incorporation of cholesterol in micelles 36) resulting in higher elimination of cholesterol through feaces. Further, low activity level of CES in intestine suggests poor esterification of dietary free cholesterol resulting in reduced absorption. 37) Hence high fecal TC levels observed in HFD+FESR rats could be attributed to high content of phytosterols in the extract (3%) as well as low activity level of CES in intestine. Low CES activity in the hepatic tissue as well, indicates poor esterification of free cholesterol and incorporation into VLDL. 38) Poor CES activity in liver and low VLDL content in plasma of HFD+FESR rats is in accordance with other published reports. 39) Higher HDL levels are documented to be physiologically beneficial. 40) Flavanoids are reported to increase HDL concentration, and lower LDL and VLDL, in hypercholesteremic animals. 41) Flavanoids (2.3%) and polyphenols (2%) found in FESR presently could thus have contributed to the increase in HDL concentration in HFD+FESR rats. High level of plasma LCAT in HFD+FESR rats further justifies the increase in HDL as, previous reports have established importance of LCAT in HDL metabolism. 42) HMG CoA reductase is the key metabolic enzyme for synthesis of cholesterol in hepatocytes. 43) Low activity level of HMG CoA reductase in liver of HFD+FESR rats indicates decreased de novo synthesis of cholesterol. Low cholesterol content in liver due to reduced HMG CoA reductase activity resulting in augmented LDL-R expression has been reported earlier. 44, 45) In this context, it is hypothesized that, reduced hepatic cholesterol content in HFD+FESR rats facilitates LDL uptake from circulation due to increased expression of LDL receptors. Decreased plasma LDL levels recorded in HFD +FESR rats corroborate this hypothesis.
Hepatic cholesterol is known to be eliminated either directly through bile or, converted to oxysterol 46) that stimulates cholesterol 7α hydroxylase to form bile acids which can be eliminated through feaces. 47) Reports on hypolipidemic activity of some natural products have been linked with higher fecal bile acid excretion. 48) FESR treatment of HFD rats seems to convert cholesterol into bile acids as noted by the higher fecal bile acid contents.
Phytocompounds like saponins inhibit pancreatic lipase activity in HFD mice leading to greater fat excretion due to reduced intestinal absorption of dietary fats. 49) Hence, increased elimination of TG through feaces of HFD+FESR rats seen in the present study can be related with the high saponin content (4.5%) in FESR. LPL hydrolyses TG from chylomicrons thereby generating nonesterified fatty acids (NEFA) for subsequent tissue uptake and metabolism. 50) HFD rats in the present study recorded suppressed PHLA while HFD+FESR rats recorded significantly elevated levels. These observations are in accordance with the previous studies in hyperlipidemic rats fed with plant products. 48) Similarly, lipoprotein lipase (LPL) is related to hydrolysis of TG molecules and lypolytic activity in tissues. Elevated LPL activity in hepatic and adipose tissues of HFD+FESR rats could be held responsible for clearance of tissue lipid load.
Results obtained in this study suggests that hypolipidemic and hypocholestemic effect of FESR are mediated via reduced absorption and that effective elimination of lipid and cholesterol is mainly due to presence of flavanoids, saponin, polyphenols and phytosterols . A comparison of results obtained in this study with lipid lowering potential of LVS suggests that, FESR (400 and 800 mg/kg) is, more effective in elevating circulating HDL levels and lowering triglyceride and cholesterol levels and maintain tissue TG metabolism. Overall, the present study has revealed the highly potent ability of SR leaf extract in controlling dyslipidemia and hence portends a strong potential for use as a therapeutic agent in lipid disorders and obesity.
